Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'COCAINE WITHDRAWAL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 49 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Miller, NS; Goldsmith, RJ
      Craving for alcohol and drugs in animals and humans: Biology and behavior

      JOURNAL OF ADDICTIVE DISEASES
    2. Orsini, C; Koob, GF; Pulvirenti, L
      Dopamine partial agonist reverses amphetamine withdrawal in rats

      NEUROPSYCHOPHARMACOLOGY
    3. Harrison, AA; Liem, YTB; Markou, A
      Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats

      NEUROPSYCHOPHARMACOLOGY
    4. Eyler, FD; Behnke, M; Garvan, CW; Woods, NS; Wobie, K; Conlon, M
      Newborn evaluations of toxicity and withdrawal related to prenatal cocaineexposure

      NEUROTOXICOLOGY AND TERATOLOGY
    5. Dagher, A; Bleicher, C; Aston, JAD; Gunn, RN; Clarke, PBS; Cumming, P
      Reduced dopamine D1 receptor binding in the ventral striatum of cigarette smokers

      SYNAPSE
    6. Haney, M; Ward, AS; Gerra, G; Foltin, RW
      Neuroendocrine effects of d-fenfluramine and bromocriptine following repeated smoked cocaine in humans

      DRUG AND ALCOHOL DEPENDENCE
    7. Kampman, KM; Volpicelli, JR; Mulvaney, F; Alterman, AI; Cornish, J; Gariti, P; Cnaan, A; Poole, S; Muller, E; Acosta, T; Luce, D; O'Brien, C
      Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity

      DRUG AND ALCOHOL DEPENDENCE
    8. Szumlinski, KK; Haskew, RE; Balogun, MY; Maisonneuve, IM; Glick, SD
      Iboga compounds reverse the behavioural disinhibiting and corticosterone effects of acute methamphetamine: Implications for their antiaddictive properties

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    9. Arnold, JC; Hunt, GE; McGregor, LS
      Effects of the cannabinoid receptor agonist CP 55,940 and the cannabinoid receptor antagonist SR 141716 on intracranial self-stimulation in Lewis rats

      LIFE SCIENCES
    10. Murphy, CA; Di Iorio, L; Feldon, J
      Effects of psychostimulant withdrawal on latent inhibition of conditioned active avoidance and prepulse inhibition of the acoustic startle response

      PSYCHOPHARMACOLOGY
    11. Suzuki, T; Abe, S; Yamaguchi, M; Baba, A; Hori, T; Shiraishi, H; Ito, T
      Effects of cocaine administration on receptor binding and subunits mRNA ofGABA(A)-benzodiazepine receptor complexes

      SYNAPSE
    12. Baumann, MH; Ayestas, MA; Dersch, CM; Brockington, A; Rice, KC; Rothman, RB
      Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens: Therapeutic implications

      SYNAPSE
    13. Al-Adawi, S; Dawe, GS; Al-Hussaini, AA
      Aboulia: neurobehavioural dysfunction of dopaminergic system

      MEDICAL HYPOTHESES
    14. Lin, D; Koob, GF; Markou, A
      Time-dependent alterations in ICSS thresholds associated with repeated amphetamine administrations

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    15. Ward, HE; Johnson, EA; Salm, AK; Birkle, DL
      Effects of prenatal stress on defensive withdrawal behavior and corticotropin releasing factor systems in rat brain

      PHYSIOLOGY & BEHAVIOR
    16. Iredale, PA; Alvaro, JD; Lee, Y; Terwilliger, R; Chen, YL; Duman, RS
      Role of corticotropin-releasing factor receptor-1 in opiate withdrawal

      JOURNAL OF NEUROCHEMISTRY
    17. Macey, DJ; Koob, GF; Markou, A
      CRF and urocortin decreased brain stimulation reward in the rat: reversal by a CRF receptor antagonist

      BRAIN RESEARCH
    18. Ghosh, S; Grasing, K
      Presynaptic dopaminergic function in the nucleus accumbens following chronic opiate treatment and precipitated withdrawal

      NEUROCHEMICAL RESEARCH
    19. Barr, AM; Fiorino, DF; Phillips, AG
      Effects of withdrawal from an escalating dose schedule of d-amphetamine onsexual behavior in the male rat

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    20. Heinz, A
      Anhedonia - a general nosology correlation of a dysfunction of the dopaminergic reward system?

      NERVENARZT
    21. Barr, AM; Phillips, AG
      Withdrawal following repeated exposure to d-amphetamine decreases responding for a sucrose solution as measured by a progressive ratio schedule of reinforcement

      PSYCHOPHARMACOLOGY
    22. TRANNGUYEN LTL; FUCHS RA; COFFEY GP; BAKER DA; ODELL LE; NEISEWANDER JL
      TIME-DEPENDENT CHANGES IN COCAINE-SEEKING BEHAVIOR AND EXTRACELLULAR DOPAMINE LEVELS IN THE AMYGDALA DURING COCAINE WITHDRAWAL

      Neuropsychopharmacology
    23. PICKWORTH WB; FANT RV
      ENDOCRINE EFFECTS OF NICOTINE ADMINISTRATION, TOBACCO AND OTHER DRUG-WITHDRAWAL IN HUMANS

      Psychoneuroendocrinology
    24. DICHIARA G
      A MOTIVATIONAL LEARNING HYPOTHESIS OF THE ROLE OF MESOLIMBIC DOPAMINEIN COMPULSIVE DRUG-USE

      JOURNAL OF PSYCHOPHARMACOLOGY
    25. SVENSSON P; HURD YL
      SPECIFIC REDUCTIONS OF STRIATAL PRODYNORPHIN AND D-1 DOPAMINE-RECEPTOR MESSENGER-RNAS DURING COCAINE ABSTINENCE

      Molecular brain research
    26. BOZARTH MA; PUDIAK CM; KUOLEE R
      EFFECT OF CHRONIC NICOTINE ON BRAIN-STIMULATION REWARD - II - AN ESCALATING DOSE REGIMEN

      Behavioural brain research
    27. GOODKIN K; SHAPSHAK P; METSCH LR; MCCOY CB; CRANDALL KA; KUMAR M; FUJIMURA RK; MCCOY V; ZHANG BT; REYBLAT S; XIN KQ; KUMAR AM
      COCAINE ABUSE AND HIV-1 INFECTION - EPIDEMIOLOGY AND NEUROPATHOGENESIS

      Journal of neuroimmunology
    28. BAUMANN MH; ROTHMAN RB
      ALTERATIONS IN SEROTONERGIC RESPONSIVENESS DURING COCAINE WITHDRAWAL IN RATS - SIMILARITIES TO MAJOR DEPRESSION IN HUMANS

      Biological psychiatry
    29. CAMP DM; DEJONGHE DK; ROBINSON TE
      TIME-DEPENDENT EFFECTS OF REPEATED AMPHETAMINE TREATMENT ON NOREPINEPHRINE IN THE HYPOTHALAMUS AND HIPPOCAMPUS ASSESSED WITH IN-VIVO MICRODIALYSIS

      Neuropsychopharmacology
    30. KOOB GF; CAINE SB; PARSONS L; MARKOU A; WEISS F
      OPPONENT PROCESS MODEL AND PSYCHOSTIMULANT ADDICTION

      Pharmacology, biochemistry and behavior
    31. KOOB GF; LEMOAL M
      DRUG-ABUSE - HEDONIC HOMEOSTATIC DYSREGULATION

      Science
    32. HERNING RI; GUO XY; BETTER WE; WEINHOLD LL; LANGE WR; CADET JL; GORELICK DA
      NEUROPHYSIOLOGICAL SIGNS OF COCAINE DEPENDENCE - INCREASED ELECTROENCEPHALOGRAM-BETA DURING WITHDRAWAL

      Biological psychiatry
    33. DICIANO P; BLAHA CD; PHILLIPS AG
      CHANGES IN DOPAMINE OXIDATION CURRENTS IN THE NUCLEUS-ACCUMBENS DURING UNLIMITED-ACCESS SELF-ADMINISTRATION OF D-AMPHETAMINE BY RATS

      Behavioural pharmacology
    34. NEISEWANDER JL; ODELL LE; TRANNGUYEN LTL; CASTANEDA E; FUCHS RA
      DOPAMINE OVERFLOW IN THE NUCLEUS-ACCUMBENS DURING EXTINCTION AND REINSTATEMENT OF COCAINE SELF-ADMINISTRATION BEHAVIOR

      Neuropsychopharmacology
    35. FITZGERALD LW; ORTIZ J; HAMEDANI AG; NESTLER EJ
      DRUGS OF ABUSE AND STRESS INCREASE THE EXPRESSION OF GLUR1 AND NMDAR1GLUTAMATE-RECEPTOR SUBUNITS IN THE RAT VENTRAL TEGMENTAL AREA - COMMON ADAPTATIONS AMONG CROSS-SENSITIZING AGENTS

      The Journal of neuroscience
    36. PICKWORTH WB; BAUMANN MH; FANT RV; ROTHMAN RB; HENNINGFIELD JE
      ENDOCRINE RESPONSES DURING ACUTE NICOTINE WITHDRAWAL

      Pharmacology, biochemistry and behavior
    37. WISE RA
      D-1-TYPE AND D-2-TYPE CONTRIBUTIONS TO PSYCHOMOTOR SENSITIZATION AND REWARD - IMPLICATIONS FOR PHARMACOLOGICAL TREATMENT STRATEGIES

      Clinical neuropharmacology
    38. PATHIRAJA A; MARAZZITI D; CASSANO GB; DIAMOND BI; BORISON RL
      PHENOMENOLOGY AND NEUROBIOLOGY OF COCAINE WITHDRAWAL - ARE THEY RELATED

      Progress in neuro-psychopharmacology & biological psychiatry
    39. SCHULTEIS G; MARKOU A; COLE M; KOOB GF
      DECREASED BRAIN REWARD PRODUCED BY ETHANOL WITHDRAWAL

      Proceedings of the National Academy of Sciences of the United Statesof America
    40. SARNYAI Z; BIRO E; GARDI J; VECSERNYES M; JULESZ J; TELEGDY G
      BRAIN CORTICOTROPIN-RELEASING FACTOR MEDIATES ANXIETY-LIKE BEHAVIOR INDUCED BY COCAINE WITHDRAWAL IN RATS

      Brain research
    41. KING GR; JOYNER C; ELLINWOOD EH
      CONTINUOUS OR INTERMITTENT COCAINE ADMINISTRATION - EFFECTS OF FLUPENTIXOL TREATMENT DURING WITHDRAWAL

      Pharmacology, biochemistry and behavior
    42. KNAPP CM; KORNETSKY C
      BROMOCRIPTINE, A D-2 RECEPTOR AGONIST, LOWERS THE THRESHOLD FOR REWARDING BRAIN-STIMULATION

      Pharmacology, biochemistry and behavior
    43. GAUVIN DV; GOULDEN KL; HOLLOWAY FA
      A 3-CHOICE HALOPERIDOL-SALINE-COCAINE DRUG DISCRIMINATION TASK IN RATS

      Pharmacology, biochemistry and behavior
    44. KING GR; JOYNER C; ELLINWOOD EH
      CONTINUOUS OR INTERMITTENT COCAINE ADMINISTRATION - EFFECTS OF AMANTADINE TREATMENT DURING WITHDRAWAL

      Pharmacology, biochemistry and behavior
    45. JAVAID JI; NOTORANGELO MP; PANDEY SC; REDDY PL; PANDEY GN; DAVIS JM
      PERIPHERAL BENZODIAZEPINE RECEPTORS ARE DECREASED DURING COCAINE WITHDRAWAL IN HUMANS

      Biological psychiatry
    46. PULVIRENTI L; KOOB GF
      DOPAMINE-RECEPTOR AGONISTS, PARTIAL AGONISTS AND PSYCHOSTIMULANT ADDICTION

      Trends in pharmacological sciences
    47. CARDOSO F; JANKOVIC J
      MOVEMENT-DISORDERS

      Neurologic clinics
    48. HITRI A; WYATT RJ
      REGIONAL DIFFERENCES IN RAT-BRAIN DOPAMINE TRANSPORTER BINDING - FUNCTION OF TIME AFTER CHRONIC COCAINE

      Clinical neuropharmacology
    49. KING GR; JOYNER CM; ELLINWOOD EH
      WITHDRAWAL FROM CONTINUOUS OR INTERMITTENT COCAINE - BEHAVIORAL RESPONSIVITY TO 5-HT(1) RECEPTOR AGONISTS

      Pharmacology, biochemistry and behavior


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/02/20 alle ore 03:02:34